Abstract:N- glycosylation is an abundant post-translational modification of most cell-surface proteins. N- glycans play a crucial role in cellular functions like protein folding, protein localization, cell–cell signaling, and immune detection. As different tissue types display different N- glycan profiles, changes in N- glycan compositions occur in tissue-specific ways with development of disease, like cancer. However, no comparative atlas resource exists for documenting N- glycome alterations across various human tissue types, particularly comparing normal and cancerous tissues. In order to study a broad range of human tissue N -glycomes, N -glycan targeted MALDI imaging mass spectrometry was applied to custom formalin-fixed paraffin-embedded tissue microarrays. These encompassed fifteen human tissue types including bladder, breast, cervix, colon, esophagus, gastric, kidney, liver, lung, pancreas, prostate, sarcoma, skin, thyroid, and uterus. Each array contained both normal and tumor cores from the same pathology block, selected by a pathologist, allowing more in-depth comparisons of the N- glycome differences between tumor and normal and across tissue types. Using established MALDI-IMS workflows and existing N- glycan databases, the N- glycans present in each tissue core were spatially profiled and peak intensity data compiled for comparative analyses. Further structural information was determined for core fucosylation using endoglycosidase F3, and differentiation of sialic acid linkages through stabilization chemistry. Glycan structural differences across the tissue types were compared for oligomannose levels, branching complexity, presence of bisecting N- acetylglucosamine, fucosylation, and sialylation. Collectively, our research identified the N- glycans that were significantly increased and/or decreased in relative abundance in cancer for each tissue type. This study offers valuable information on a wide scale for both normal and cancerous tissues, serving as a reference for future studies and potential diagnostic applications of MALDI-IMS.

N-GlycositeAtlas: a database resource for mass spectrometry-based human N-linked glycoprotein and glycosylation site mapping

Mass spectrometry-based structure-specific N- glycoproteomics and biomedical applications

Comprehensive Mapping of Protein N-Glycosylation in Human Liver by Combining Hydrophilic Interaction Chromatography and Hydrazide Chemistry

Sensitive <i>N</i>-Glycopeptide Profiling of Single and Rare Cells Using an Isobaric Labeling Strategy without Enrichment

Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis.

High-Throughput Determination of the Site-Specific N.Sialoglycan Occupancy Rates by Differential Oxidation of Glycoproteins Followed with Quantitative Glycoproteomics Analysis

Proteomics Analysis of O-GalNAc Glycosylation in Human Serum by an Integrated Strategy

In vitro and in vivo enzymatic syntheses and mass spectrometric database for N-glycans and o-glycans

O-GlcNAcAtlas: A Database of Experimentally Identified O-GlcNAc Sites and Proteins

Con A Affinity Glycoproteomics of Normal Human Liver Tissue

pGlyco 2.0 enables precision N-glycoproteomics with comprehensive quality control and one-step mass spectrometry for intact glycopeptide identification

Convenient and Precise Strategy for Mapping N-Glycosylation Sites Using Microwave-Assisted Acid Hydrolysis and Characteristic Ions Recognition

Glycosite Analysis in Glycoproteomics by Mass Spectrometry

Glycans, Glycosite, and Intact Glycopeptide Analysis of N-Linked Glycoproteins Using Liquid Handling Systems

pGlyco: a pipeline for the identification of intact N-glycopeptides by using HCD- and CID-MS/MS and MS3

Chromatograms and Mass Spectra of High-Mannose and Paucimannose N -Glycans for Rapid Isomeric Identifications

Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides

An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry

High-throughput site-specific N-glycoproteomics reveals glyco-signatures for liver disease diagnosis

Uncovering missing glycans and unexpected fragments with pGlycoNovo for site-specific glycosylation analysis across species

Global mapping of glycosylation pathways in human-derived cells